Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting-Reference-Cited by-同舟云学术

Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting

Published:2023-10 Issue:7 Volume:23 Page:712-720.e3
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

D'Onofrio Raffaella,Omarini Claudia,Toss Angela,Sperduti Isabella,Piacentini Federico,Barbolini Monica,Cortesi Laura,Barbieri Elena,Pettorelli Elisa,Chiavelli Chiara,Dominici Massimo,Moscetti Luca^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. The modern landscape of endocrine therapy for premenopausal women with breast cancer;Rossi;Breast Care,2015

3. SOFT Investigators; International Breast Cancer Study Group. Adjuvant ovarian suppression in premenopausal breast cancer;Francis;N Engl J Med,2015

4. TEXT and SOFT Investigators; International Breast Cancer Study Group Adjuvant exemestane with ovarian suppression in premenopausal breast cancer;Pagani;N Engl J Med,2014

5. TEXT and SOFT Investigators; International Breast Cancer Study GroupAdjuvant exemestane with ovarian suppression in premenopausal breast cancer;Pagani;N Engl J Med,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tamoxifen;Reactions Weekly;2024-06-29

2. PKIB Inhibits Autophagy to Regulate Tamoxifen Resistance in Breast Cancer with Estrogen Receptor-Positive Status;J BIOL REG HOMEOS AG;2023